8MO The efficacy and safety of TQ-B3101 monotherapy in the first-line treatment in patients with ROS1-positive non-small cell lung cancer
Titel:
8MO The efficacy and safety of TQ-B3101 monotherapy in the first-line treatment in patients with ROS1-positive non-small cell lung cancer
Auteur:
Lu, S. Pan, H. Wu, L. Yao, Y. He, J. Wang, Y. Wang, X. Wang, X. Cai, X. Yu, Y. Ma, Z. Min, X. Yang, Z. Cao, L. Yang, H. Shu, Y. Zhuang, W. Cang, S. Fang, J. Li, K.